levodopa has been researched along with Chorea Disorders in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (44.94) | 18.7374 |
1990's | 20 (22.47) | 18.2507 |
2000's | 11 (12.36) | 29.6817 |
2010's | 13 (14.61) | 24.3611 |
2020's | 5 (5.62) | 2.80 |
Authors | Studies |
---|---|
Girasole, AE; Kreitzer, AC; Lee, HY; Nelson, AB; Ptáček, LJ | 1 |
Daneault, JF; Duval, C; Lee, SI; Liu, Y; Oubre, B | 1 |
Belvisi, D; Berardelli, A; Bologna, M; Conte, A; Guerra, A; Kamble, N; Pal, PK; Valls-Solè, J | 1 |
Bachoud-Lévi, AC; Blasco-Amaro, JA; Capuano, A; Isabel-Gómez, R; Martín-Gómez, C; Nou-Fontanet, L; Ortigoza-Escobar, JD; Zorzi, G | 1 |
Araki, A; Endo, T; Kazuta, T; Terao, S; Torii, R; Yokoi, K | 1 |
Lim, SY; Ng, RX; Tan, AH | 1 |
Angriman, M; Carecchio, M; Frattini, D; Fusco, C; Garavaglia, B; Invernizzi, F; Iodice, A; Mantuano, E; Mencacci, NE; Salerno, GG; Spagnoli, C; Veneziano, L; Zorzi, G | 1 |
Hamel, W; Hariz, M; Köppen, JA; Krack, P; Moll, CKE; Müller, D | 1 |
Kim, JS; Yoo, SW | 1 |
Álvarez-Sabin, J; Boronat-Guerrero, S; Hernández-Vara, J; Salvado, M | 1 |
Borroni, B; Cotelli, MS; Filosto, M; Marchina, E; Padovani, A; Premi, E | 1 |
Hattori, N; Ishiguro, Y; Kawajiri, S; Noda, K; Okuma, Y; Tomizawa, Y; Tosaka, Y | 1 |
Jeon, BS; Park, H; Park, SH; Shin, JH | 1 |
Albanese, A; Del Sorbo, F | 1 |
Domitrz, I; Friedman, A; Kwiecinski, H; Lee, HY; Ptacek, L; Zakrzewska-Pniewska, B | 1 |
Jurjevic, A; Kovacevic, M; Ljubicic, D; Mrsic-Pelcic, J; Perkovic, O; Rudez, J; Vitezic, D; Vitezic, M | 1 |
Chan, LL; Tan, EK | 1 |
Duval, C; Edwards, R; Jog, M; Mann, RK; Zhou, J | 1 |
Mink, JW; Zinner, SH | 1 |
Artuch, R; Campistol, J; Fernandez-Alvarez, E; Fons, C; Garcia-Cazorla, A; Martorell, L; Ormazabal, A; Rizzu, P | 1 |
HIRSCHMANN, J; MAYER, K | 1 |
Bezard, E; Brotchie, JM; Crossman, AR; Grimée, R; Hill, MP; Klitgaard, H; Michel, A | 1 |
Filiano, JJ; Furukawa, Y; Kish, SJ | 1 |
Asmus, F; Gasser, T; Horber, V; Munz, M; Pohlenz, J; Schöning, M; Schwabe, D; Zimprich, A | 1 |
Blau, N; de Villemeur, TB; Doummar, D; Moller, LB; Roubergue, A; Roze, E; Vidailhet, M | 1 |
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Visanji, NP | 1 |
Still, CN | 1 |
Benchet, ML; Landrieu, P; Lapresle, J; Tardieu, M | 1 |
Diamond, SG; Markham, CH | 2 |
Coffey, CE; Ferren, EL; Olanow, CW; Ross, DR; Walker, JI | 1 |
Hardie, RJ; Lees, AJ; Stern, GM | 1 |
Mitsuma, T; Miura, N; Sakakibara, T; Sobue, G; Takahashi, M; Takeda, A; Terao, S | 1 |
Crossman, AR; Page, RD; Sambrook, MA | 1 |
Mark, MH; Sage, JI | 1 |
Kanazawa, I; Kimura, M; Murata, M | 1 |
Agid, Y; Bonnet, AM; Dubois, B; Lefebvre-Caparros, D; Marconi, R; Vidailhet, M | 1 |
Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR | 1 |
Chase, TN; Engber, TM; Mouradian, MM | 1 |
Hirato, M; Horikoshi, S; Kawashima, Y; Ohye, C; Satake, K; Shibazaki, T | 1 |
Cornelius, L; Factor, SA; Ingenito, A; Sanchez-Ramos, JR; Sheldon, C; Singer, C; Weiner, WJ | 1 |
Chase, TN; Papa, SM | 1 |
Hirato, M; Horikoshi, S; Ishihara, J; Ohye, C; Shibazaki, T | 1 |
Benabid, AL; Benazzouz, A; Deuschl, G; Krack, P; Limousin, P; Pollak, P | 1 |
Andrews, TC; Brooks, DJ; Chaudhuri, KR; Clough, C; Hu, MT; Reuter, I | 1 |
Cabral, J; Gálvez-Jiménez, N; Hanson, MR | 1 |
Benabou, R; Cubo, E; Goetz, CG; Gracies, JM; Leurgans, S; Olanow, CW; Raman, R | 1 |
Ohye, C | 1 |
Shute, CC | 1 |
Bedard, P; Marsden, CD; Parkes, JD | 1 |
Lees, AJ; Shaw, KM; Stern, GM | 1 |
Klawans, HL; Weiner, WJ | 1 |
Chase, TN | 1 |
Sears, ES | 1 |
Calne, DB; Eisler, T | 1 |
Cler, JM; Mathé, JF; Venisse, JL | 1 |
Marais, C | 1 |
Agnoli, A; Casacchia, M; Ruggieri, S | 1 |
Godwin-Austen, RB | 1 |
Bathien, N; Rondot, P | 1 |
Durocher, AM; Graux, P | 1 |
Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
Barrett, RE; Cote, LJ; Fahn, S; Isgreen, WP; Lesser, RP; Snider, SR | 1 |
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
Rektor, I | 1 |
Reitter, B; Weisser, J | 1 |
Boucher, R; Dankova, J; Larochelle, L; Péchadre, JC; Poirier, LJ | 1 |
Fleming, AM; Lenman, JA; Reid, A; Turnbull, MJ | 1 |
Debono, AG; Marsden, CD; Parkes, JD | 1 |
Chalmers, RJ; Johnson, RH; McLellan, DL | 1 |
Patterson, JF | 1 |
Mawdsley, C | 1 |
Corsini, GU; Mangoni, A; Marrosu, F; Spissu, A | 1 |
Marsden, CD; Pires, M; Quinn, NP; Scaravilli, F; Steiger, MJ | 1 |
Lees, AJ; Turjanski, N | 1 |
Mark, MH; McHale, DM; Sage, JI; Sonsalla, PK; Vitagliano, D | 1 |
Cho, F; Kanazawa, I; Kimura, M; Murata, M; Tanaka, Y | 1 |
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ | 2 |
Bergen, M; Hening, WA; McHale, D; Sage, JI; Walters, AS | 1 |
Boyce, S; Clarke, CE; Crossman, AR; Luquin, R; Mitchell, IJ; Peggs, D; Robertson, RG; Sambrook, MA | 1 |
Klawans, HL | 1 |
Diamond, SG; Hoehn, MM; Markham, CH; McDowell, FH; Muenter, MD | 1 |
Cho, F; Kanazawa, I; Tanaka, Y | 1 |
Marsden, CD | 1 |
Goto, A; Kosaka, K; Miyazaki, S; Narabayashi, H | 1 |
Rosin, AJ | 1 |
Markham, CH | 1 |
Diamond, SG; Markham, CH; Treciokas, LJ | 1 |
14 review(s) available for levodopa and Chorea Disorders
Article | Year |
---|---|
Dystonia, chorea, hemiballismus and other dyskinesias.
Topics: Chorea; Dyskinesias; Dystonia; Dystonic Disorders; Humans; Levodopa | 2022 |
Systematic review of drug therapy for chorea in NXK2-1-related disorders: Efficacy and safety evidence from case studies and series.
Topics: Carbidopa; Chorea; Clonazepam; Humans; Levodopa; Methylphenidate; Tetrabenazine | 2023 |
The Pioneering and Unknown Stereotactic Approach of Roeder and Orthner from Göttingen. Part II: Long-Term Outcome and Postmortem Analysis of Bilateral Pallidotomy in the Pre-Levodopa Era.
Topics: Adult; Aged; Chorea; Diagnosis; Dyskinesias; Female; Globus Pallidus; Humans; Imaging, Three-Dimensional; Levodopa; Male; Middle Aged; Movement Disorders; Pallidotomy; Parkinson Disease; Psychosurgery; Stereotaxic Techniques; Thalamus; Treatment Outcome; Tremor | 2018 |
[Chorea due to TITF1/NKX2-1 mutation: phenotypical description and therapeutic response in a family].
Topics: Adolescent; Adult; Age of Onset; Brain; Carbidopa; Chorea; Congenital Hypothyroidism; Drug Therapy, Combination; Exons; Female; Humans; Infant, Newborn; Intellectual Disability; Levodopa; Magnetic Resonance Imaging; Nuclear Proteins; Pedigree; Phenotype; Pregnancy; Sequence Deletion; Thyroid Nuclear Factor 1; Transcription Factors; Young Adult | 2013 |
Levodopa-induced dyskinesias and their management.
Topics: Antiparkinson Agents; Chorea; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Levodopa; Parkinson Disease; Subthalamic Nucleus | 2008 |
Involuntary movement disorders.
Topics: Brain; Chorea; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Humans; Huntington Disease; Levodopa; Meige Syndrome; Movement Disorders; Parasympatholytics; Parkinson Disease | 1984 |
Striatal dopaminoceptive system changes and motor response complications in L-dopa-treated patients with advanced Parkinson's disease.
Topics: Animals; Chorea; Corpus Striatum; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Levodopa; Motor Skills; Neurologic Examination; Parkinson Disease, Secondary; Receptors, Dopamine | 1993 |
Use of selective thalamotomy for various kinds of movement disorder, based on basic studies.
Topics: Antiparkinson Agents; Cerebral Hemorrhage; Chorea; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Electrodes, Implanted; Electroencephalography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Movement Disorders; Muscle Rigidity; Paresthesia; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Surgery, Computer-Assisted; Thalamic Nuclei; Tomography, X-Ray Computed; Treatment Outcome; Tremor | 2000 |
Chemical transmitter systems in the brain.
Topics: Acetylcholine; Brain; Chorea; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Humans; Learning; Levodopa; Memory; Neural Inhibition; Neural Pathways; Neurotransmitter Agents; Norepinephrine; Parasympathetic Nervous System; Serotonin; Substantia Nigra; Sympathetic Nervous System; Synapses; Synaptic Transmission | 1975 |
The pharmacology of choreatic movement disorders.
Topics: Acetylcholine; Acute Disease; Amphetamine; Chorea; Dopamine; gamma-Aminobutyric Acid; Hepatolenticular Degeneration; Humans; Huntington Disease; Hyperthyroidism; Levodopa; Lupus Erythematosus, Systemic; Movement Disorders; Serotonin | 1976 |
The pathogensis and medical treatment of extrapyramidal disease.
Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Administration Schedule; Dystonia; Female; gamma-Aminobutyric Acid; Glutamates; Haloperidol; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tic Disorders | 1979 |
[Duality of dopaminergic receptors. Pharmacologic and clinical perspectives].
Topics: Animals; Apomorphine; Benzamides; Chorea; Fluorescent Antibody Technique; Guinea Pigs; Haloperidol; Humans; Levodopa; Movement Disorders; Parkinson Disease; Rats; Receptors, Dopamine | 1978 |
Chorea.
Topics: Antipsychotic Agents; Cholinergic Fibers; Chorea; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Reserpine; Serotonin; Somatostatin; Substance P | 1987 |
Parkinson's disease and levodopa. A five-year follow-up and review.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Animals; Athetosis; Basal Ganglia; Chorea; Corpus Striatum; Dementia; Depression; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Sexual Behavior; Substantia Nigra; Vomiting | 1974 |
4 trial(s) available for levodopa and Chorea Disorders
Article | Year |
---|---|
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Bromocriptine; Chorea; Double-Blind Method; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1993 |
Letter: Chorea and torsion in parkinsonism.
Topics: Chorea; Humans; Levodopa; Parkinson Disease; Torsion Abnormality | 1976 |
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry.
Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents | 1978 |
Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
Topics: Aged; Antiparkinson Agents; Chorea; Clinical Trials as Topic; Confusion; Dioxoles; Dopamine; Drug Evaluation; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Motor Skills; Muscle Rigidity; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Piperazines; Pyrimidines; Tremor | 1975 |
71 other study(ies) available for levodopa and Chorea Disorders
Article | Year |
---|---|
Striatal Indirect Pathway Dysfunction Underlies Motor Deficits in a Mouse Model of Paroxysmal Dyskinesia.
Topics: Animals; Chorea; Corpus Striatum; Disease Models, Animal; Dyskinesias; Female; Levodopa; Male; Mice; Neurons | 2022 |
A Kinematic Data-Driven Approach to Differentiate Involuntary Choreic Movements in Individuals With Neurological Conditions.
Topics: Biomechanical Phenomena; Chorea; Humans; Huntington Disease; Levodopa; Parkinson Disease | 2022 |
Effectiveness of levodopa treatment for diabetic chorea with reduced striatal accumulation in dopamine transporter SPECT: a case report.
Topics: Aged; Amines; Chorea; Corpus Striatum; Cyclohexanecarboxylic Acids; Diabetes Complications; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Dyskinesias; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Levodopa; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2017 |
Osmotic Demyelination Syndrome With Evolving Movement Disorders.
Topics: Acute Disease; Adult; Akinetic Mutism; Athetosis; Benserazide; Chorea; Demyelinating Diseases; Dopamine Agents; Drug Combinations; Fluid Therapy; Gastroenteritis; Humans; Hyponatremia; Levodopa; Male; Myelinolysis, Central Pontine; Parkinsonian Disorders; Saline Solution; Time Factors | 2018 |
Restless Legs Syndrome in NKX2-1-related chorea: An expansion of the disease spectrum.
Topics: Adult; Brain; Child; Child, Preschool; Chorea; Cohort Studies; Dopamine Agents; Family Health; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Mutation; Pituitary Gland; Restless Legs Syndrome; Thyroid Nuclear Factor 1 | 2019 |
Contralateral levodopa-induced hemichorea in a patient with severe asymmetric Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Chorea; Drug Tapering; Female; Humans; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2020 |
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype.
Topics: Antiparkinson Agents; Athetosis; Benzothiazoles; Chorea; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Magnetic Resonance Imaging; Middle Aged; Mutation; Neurologic Examination; Phenotype; Positron-Emission Tomography; Pramipexole; Protein Serine-Threonine Kinases; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tremor | 2013 |
Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis.
Topics: Carbidopa; Chorea; Disease Progression; Dopamine Agonists; Drug Combinations; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Myelinolysis, Central Pontine; Parkinsonian Disorders | 2015 |
A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea.
Topics: Amantadine; Antiparkinson Agents; Benzothiazoles; Brain; Chorea; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Pramipexole; Spinocerebellar Ataxias; TATA-Box Binding Protein; Trinucleotide Repeats | 2016 |
Paroxysmal non-kinesigenic dyskinesia caused by the mutation of MR-1 in a large Polish kindred.
Topics: Aged; Chorea; Dopamine Agents; Female; Humans; Levodopa; Male; Menopause; Muscle Proteins; Pedigree; Poland; Pregnancy; White People | 2009 |
Sildenafil induced choreoathetosis in men with Parkinson's disease.
Topics: Antiparkinson Agents; Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2010 |
'Diphasic' levodopa-induced chorea in multiple system atrophy.
Topics: Chorea; Dopamine Agents; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy | 2010 |
Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Chorea; Dyskinesia, Drug-Induced; Extremities; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Severity of Illness Index | 2010 |
Movement disorders ii: chorea, dystonia, myoclonus, and tremor.
Topics: Child; Chorea; Dopamine Agents; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Levodopa; Lupus Erythematosus, Systemic; Myoclonus; Tremor | 2010 |
TITF-1 gene mutation in a case of sporadic non-progressive chorea. Response to levodopa treatment.
Topics: Age of Onset; Child; Child, Preschool; Chorea; Dopamine Agents; Female; Humans; Levodopa; Mutation; Nuclear Proteins; Thyroid Nuclear Factor 1; Transcription Factors | 2012 |
[ON THE CONTROL OF AKINESIA AND OTHER EXTRAPYRAMIDAL MOTOR DISORDERS WITH L-DOPA (L-DIHYDROXYPHENYLALANINE)].
Topics: Chorea; Dihydroxyphenylalanine; Electromyography; Extrapyramidal Tracts; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Neurosurgery; Neurosurgical Procedures; Parkinsonian Disorders; Stereotaxic Techniques; Torticollis; Tremor | 1964 |
Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.
Topics: Animals; Chorea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levetiracetam; Levodopa; Macaca fascicularis; MPTP Poisoning; Piracetam | 2004 |
Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.
Topics: Amantadine; Antiparkinson Agents; Child; Chorea; Dopamine Agents; Dyskinesia, Drug-Induced; GTP Cyclohydrolase; Heterozygote; Humans; Levodopa; Male; Parkinson Disease; Pedigree; Phenotype; Point Mutation | 2004 |
A novel TITF-1 mutation causes benign hereditary chorea with response to levodopa.
Topics: Child; Child, Preschool; Chorea; Codon, Nonsense; Congenital Hypothyroidism; DNA Mutational Analysis; Dopamine Agents; Exons; Fatal Outcome; Female; Genetic Testing; Humans; Levodopa; Male; Nuclear Proteins; Pedigree; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thyroid Nuclear Factor 1; Transcription Factors; Treatment Outcome | 2005 |
Long-term follow-up and adult outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency.
Topics: Adolescent; Adult; Antiparkinson Agents; Athetosis; Child; Child, Preschool; Chorea; Dose-Response Relationship, Drug; Dystonia; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Levodopa; Long-Term Care; Muscle Hypotonia; Neurologic Examination; Phenylketonurias; Phosphorus-Oxygen Lyases; Pterins; Treatment Outcome | 2006 |
Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Chorea; Disease Models, Animal; Female; Histamine Agonists; Levodopa; Parkinson Disease; Receptors, Histamine H3 | 2006 |
[Sex-linked, nonprogressive, familial chorea].
Topics: Adolescent; Child; Child, Preschool; Chorea; Chronic Disease; Female; Genes, Recessive; Genetic Carrier Screening; Humans; Levodopa; Male; Pedigree; Prognosis; X Chromosome | 1984 |
One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease.
Topics: Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Hypotension; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1984 |
"On-off" syndrome treated with lithium carbonate: a case report.
Topics: Adult; Athetosis; Chorea; Humans; Levodopa; Lithium; Lithium Carbonate; Male; Parkinson Disease; Receptors, Dopamine | 1981 |
Levodopa induced chorea in Meige syndrome.
Topics: Adult; Basal Ganglia Diseases; Chorea; Dose-Response Relationship, Drug; Female; Humans; Levodopa | 1983 |
Evidence to support early levodopa therapy in Parkinson disease.
Topics: Athetosis; Chorea; Drug Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
[Disturbance of hypothalamic-pituitary hormone secretion in familial chorea-acanthocytosis].
Topics: Acanthocytes; Adult; Chorea; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Middle Aged; Pituitary-Adrenal System; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1995 |
Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
Topics: Afferent Pathways; Animals; Apomorphine; Axonal Transport; Brain Mapping; Chorea; Dyskinesia, Drug-Induced; Dystonia; Globus Pallidus; Horseradish Peroxidase; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Stereotaxic Techniques; Thalamus; Wheat Germ Agglutinins | 1993 |
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.
Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating | 1995 |
Roles of dopamine and its receptors in generation of choreic movements.
Topics: Afferent Pathways; Animals; Brain Mapping; Cerebral Cortex; Choline O-Acetyltransferase; Chorea; Corpus Striatum; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Kainic Acid; Levodopa; Macaca; Neurons; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Substantia Nigra; Synapses; Tyrosine 3-Monooxygenase | 1993 |
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
Topics: Activities of Daily Living; Adult; Aged; Chorea; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine D1; Video Recording | 1994 |
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1994 |
Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
Topics: Basal Ganglia; Blood Glucose; Brain Mapping; Cerebral Cortex; Chorea; Dominance, Cerebral; Dystonia; Energy Metabolism; Humans; Hyperkinesis; Levodopa; Muscle Rigidity; Neural Pathways; Oxygen Consumption; Parkinson Disease; Thalamic Nuclei; Tomography, Emission-Computed | 1993 |
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Chorea; Dyskinesia, Drug-Induced; Dystonia; Excitatory Amino Acid Antagonists; Female; Isoquinolines; Levodopa; Macaca fascicularis; Macaca mulatta; Male; Parkinson Disease, Secondary; Receptors, N-Methyl-D-Aspartate | 1996 |
Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
Topics: Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Chorea; Deoxyglucose; Dyskinesia, Drug-Induced; Electrodes, Implanted; Energy Metabolism; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Levodopa; Motor Neurons; Neural Pathways; Neurologic Examination; Parkinson Disease; Stereotaxic Techniques; Thalamic Nuclei; Tomography, Emission-Computed; Tremor | 1995 |
From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
Topics: Adult; Antiparkinson Agents; Chorea; Dyskinesia, Drug-Induced; Dystonia; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Periodicity; Thalamic Nuclei | 1999 |
Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
Topics: Aged; Antiparkinson Agents; Chorea; Diagnosis, Differential; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed; Treatment Outcome; Trinucleotide Repeats | 2000 |
Dopa-resistant parkinsonism, oculomotor disturbances, chorea, mirror movements, dyspraxia, and dementia: the expanding clinical spectrum of hypoparathyroidism. A case report.
Topics: Aged; Antiparkinson Agents; Apraxias; Brain Diseases; Calcinosis; Chorea; Chronic Disease; Dementia; Diagnosis, Differential; Drug Tolerance; Female; Humans; Hypoparathyroidism; Levodopa; Magnetic Resonance Imaging; Oculomotor Nerve Diseases; Parkinsonian Disorders; Stereotypic Movement Disorder; Videotape Recording | 2000 |
Early morning off-medication dyskinesias, dystonia, and choreic subtypes.
Topics: Adult; Aged; Antiparkinson Agents; Brain Tissue Transplantation; Chorea; Dyskinesia, Drug-Induced; Dystonic Disorders; Female; Fetal Tissue Transplantation; Globus Pallidus; Humans; Incidence; Levodopa; Male; Middle Aged; Parkinson Disease | 2001 |
"Off period" dystonia and "on period" choreoathetosis in levodopa-treated patients with Parkinson's disease.
Topics: Athetosis; Chorea; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease | 1977 |
Rational approaches to the pharmacotherapy of chorea.
Topics: Acetylcholine; Chorea; Dopamine; Drug Evaluation; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Huntington Disease; Levodopa; Norepinephrine; Serotonin | 1976 |
Therapeutics of disordered movement.
Topics: Carbidopa; Chorea; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease; Receptors, Cholinergic; Receptors, Dopamine; Tremor | 1977 |
[Therapeutic use of tiapride in movement disorders].
Topics: Benzamides; Chorea; Chronic Disease; Drug Tolerance; Female; Humans; Huntington Disease; Levodopa; Movement Disorders; Parkinson Disease | 1978 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid | 1979 |
[Abnormal movements induced by psychotropic drugs].
Topics: Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Lithium; Movement Disorders; Parkinson Disease, Secondary; Psychotropic Drugs; Receptors, Dopamine; Receptors, Drug; Tremor | 1979 |
[Value of sulpiride and tiapride in geriatrics. Antagonism between Parkinson disease and chorea].
Topics: Aged; Benzamides; Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Sulpiride; Tiapamil Hydrochloride | 1979 |
Methylphenidate-induced chorea: case report and pharmacologic implications.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Child; Child, Preschool; Chorea; Dopamine; Dyskinesia, Drug-Induced; Guinea Pigs; Humans; Hyperkinesis; Levodopa; Male; Methylphenidate; Stereotyped Behavior | 1978 |
Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy.
Topics: Adolescent; Adult; Aged; Chorea; Encephalitis; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
[Drug modification of the dopaminergic system in chorea].
Topics: Adult; Aged; Chorea; Extrapyramidal Tracts; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Receptors, Dopamine | 1978 |
[Familial paroxysmal choreoathetosis. Clinical course, L-dopa-effect (author's transl)].
Topics: Adolescent; Athetosis; Child; Child, Preschool; Chorea; Humans; Levodopa; Male | 1978 |
Stereotaxic lesions and movement disorders in monkeys.
Topics: Animals; Brain; Brain Mapping; Butyrophenones; Catalepsy; Catatonia; Cerebellum; Chorea; Haplorhini; Humans; Hypothalamus, Posterior; Levodopa; Mesencephalon; Methyltyrosines; Monoamine Oxidase Inhibitors; Motor Cortex; Movement Disorders; Parasympatholytics; Phenothiazines; Pons; Reserpine; Stereotaxic Techniques; Substantia Nigra; Tremor | 1975 |
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Topics: Amantadine; Chorea; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methylhistamines; Middle Aged; Movement Disorders; Parkinson Disease; Phenylacetates; Tremor | 1977 |
alpha and beta Dopamine receptors?
Topics: Apomorphine; Chorea; Haloperidol; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Torticollis | 1976 |
Chronic thallitoxicosis: treatment of the choreiform sequelae.
Topics: Adult; Chorea; Chronic Disease; Humans; Levodopa; Male; Thallium | 1975 |
Diseases of the central nervous system. Involuntary movements.
Topics: Athetosis; Central Nervous System Diseases; Chorea; Face; Humans; Levodopa; Movement Disorders; Myoclonus; Parkinson Disease; Spasm; Tic Disorders; Torticollis; Tremor | 1975 |
Treatment of Sydenham's chorea with a combination of L-dopa and a peripheral dopa decarboxylase inhibitor.
Topics: Acute Disease; Adolescent; Carbidopa; Chorea; Drug Therapy, Combination; Homovanillic Acid; Humans; Hydrazines; Levodopa; Male; Recurrence | 1975 |
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Carbidopa; Central Nervous System Diseases; Chorea; Diagnosis, Differential; Drug Combinations; Female; Humans; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Spinal Cord | 1992 |
Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Topics: 4-Aminobutyrate Transaminase; Adult; Aged; Aminocaproates; Chorea; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Neurologic Examination; Parkinson Disease; Vigabatrin | 1992 |
Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced chorea.
Topics: Chorea; Delayed-Action Preparations; Humans; Intestinal Absorption; Levodopa; Parkinson Disease; Time Factors | 1991 |
Choreic movements in the macaque monkey induced by kainic acid lesions of the striatum combined with L-dopa. Pharmacological, biochemical and physiological studies on neural mechanisms.
Topics: Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Chorea; Corpus Striatum; Electrophysiology; Kainic Acid; Levodopa; Macaca fascicularis; Male; Methamphetamine; Movement; Nervous System; Neurons; Neurotransmitter Agents; Volition | 1990 |
(+)-PHNO: a new anti-parkinsonian agent which does not induce chorea in MPTP-treated squirrel monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Cutaneous; Animals; Antiparkinson Agents; Athetosis; Chorea; Dopamine Agents; Levodopa; Oxazines; Saimiri | 1990 |
A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea.
Topics: Chorea; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Levodopa; Parkinson Disease; Videotape Recording | 1990 |
Induction of chorea and dystonia in parkinsonian primates.
Topics: Animals; Chorea; Dystonia; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary | 1990 |
Characterisation of dyskinesias induced by L-dopa in MPTP-treated squirrel monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Chorea; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Saimiri | 1990 |
Effect of age at onset on progression and mortality in Parkinson's disease.
Topics: Aging; Athetosis; Chorea; Disability Evaluation; Humans; Levodopa; Middle Aged; Parkinson Disease | 1989 |
'Choreic' movement induced by unilateral kainate lesion of the striatum and L-DOPA administration in monkey.
Topics: Animals; Chorea; Corpus Striatum; Dopamine; Kainic Acid; Levodopa; Macaca fascicularis; Male; Substantia Nigra; Synaptic Transmission | 1986 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; Myoclonus; Phenothiazines; Propranolol; Reserpine; Tetrabenazine; Tic Disorders; Torticollis; Tourette Syndrome; Tremor | 1973 |
Importance of the cerebellar hemisphere in production of tremulous movement or choreo-dystonic movement in monkeys.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Cerebellum; Chorea; Disease Models, Animal; Drug Combinations; Enzyme Inhibitors; Levodopa; Macaca; Muscular Diseases; Tremor | 1974 |
Clinical features, etiology and treatment of facial dyskinesias in the elderly.
Topics: Age Factors; Aged; Brain; Brain Damage, Chronic; Brain Stem; Chorea; Dementia; Dopamine; Face; Female; Haloperidol; Humans; Intracranial Arteriosclerosis; Levodopa; Lip; Male; Movement Disorders; Parasympathomimetics; Parkinson Disease; Phenothiazines; Tongue | 1974 |
The "on-off" side effect of L-DOPA.
Topics: Age Factors; Amitriptyline; Aromatic Amino Acid Decarboxylase Inhibitors; Athetosis; Carbidopa; Catechol O-Methyltransferase Inhibitors; Chlordiazepoxide; Chorea; Desipramine; Diazepam; Dietary Proteins; Enzyme Inhibitors; Female; Humans; Imipramine; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Physical Exertion; Picolinic Acids; Prochlorperazine; Sex Factors; Stress, Psychological | 1974 |